Age appears to be a strong predictor of MS disease activity. With increasing age, relapse frequency and new inflammatory MRI lesions decline, and the accumulation of neurological disability accelerates. Also, there is a relative lack of efficacy of disease modifying therapies in people with progressive MS. Join Dr. Olaf Stuve to discuss disease progression in MS and options for people with a progressive disease course.